Positionen, Richtlinien & Downloads

Date Title Type Download
2020/07 Halbjahresbericht 2020 Brochure (2 MB)
2020/06 EFPIA Disclosure Code Self-Certification Scheme Policy (143 KB)
2020/05 Roche Position on TRIPS and the Doha Declaration Position (387 KB)
2020/04 Assessing the Value of Roche Products and Services Position (322 KB)
2016/10 Biodiversity Position (219 KB)
2020/04 Biotechnology - Safety Health and Environmental Aspects Position (338 KB)
2020/04 Clinical Research Position (446 KB)
2016/10 Counterfeiting Position (443 KB)
2020/04 Energy Conservation Position (378 KB)
2020/04 Greenhouse gases / Climate Change Position (374 KB)
2020/04 Position on Human Specimen Resources (Biobanks) Position (225 KB)
2020/04 Human Stem Cells Position (467 KB)
2020/04 Landfills / Contaminated Soil Position (304 KB)
2020/04 Nanotechnology Position (444 KB)
2020/04 Personalised Healthcare Position (250 KB)
2020/04 Pharmaceuticals in the Environment Position (378 KB)
2020/04 Prevention of Misuse of Biological Materials and Toxins for Biowarfare Position (434 KB)
2020/04 Pricing Position (412 KB)
2020/04 R&D for Neglected Tropical Disease Position (253 KB)
2020/04 Similar Biotherapeutic Products - Biosimilars Position (302 KB)
2020/04 Water Position (433 KB)
2020/04 Pollution Prevention and Reduction Position (461 KB)
2020/04 Waste Management Position (297 KB)
2020/04 Product Stewardship Position (591 KB)
2020/04 Pre-Approval Access to Investigational Medicinal Products Position (488 KB)
2020/04 Safety, Security, Health and Environmental Protection (SHE) in the supply chain Position (490 KB)
2020/04 Human Rights Position (360 KB)
2020/04 Human Genetic and Genomic Research Position (433 KB)
2020/04 Roche’s Position on Access to & Use of Real World Data Position (425 KB)
2020/04 Animal Research at Roche Position (413 KB)
2020/02 Verhaltenskodex der Roche-Gruppe (Chinesisch) Policy (3 MB)
2020/02 Verhaltenskodex der Roche-Gruppe (Deutsch) Policy (3 MB)
2020/02 Roche Group Code of Conduct (Spanish) Policy (3 MB)
2020/02 Verhaltenskodex der Roche-Gruppe (Französisch) Policy (3 MB)
2020/02 Verhaltenskodex der Roche-Gruppe - Nachtrag für Frankreich (Französisch) Policy (14 MB)
2020/02 Verhaltenskodex der Roche-Gruppe (Italienisch) Policy (3 MB)
2020/02 Verhaltenskodex der Roche-Gruppe (Portugiesisch - Brasilien) Policy (3 MB)
2020/02 Verhaltenskodex der Roche-Gruppe (Japanisch) Policy (3 MB)
2020/02 Verhaltenskodex der Roche-Gruppe (Portugiesisch) Policy (3 MB)
2020/02 Verhaltenskodex der Roche-Gruppe (Russisch) Policy (3 MB)
2020/02 Verhaltenskodex der Roche-Gruppe (Türkisch) Policy (3 MB)
2020/02 Verhaltenskodex der Roche-Gruppe (Englisch) Policy (3 MB)
2020/01 Roche in Kürze 2019 Brochure (1 MB)
2020/01 Finanzbericht 2019 Brochure (4 MB)
2020/01 Geschäftsbericht 2019 Brochure (8 MB)
2019/12 Supplier Code of Conduct (French) Guidelines (1 MB)
2016/08 Supplier Code of Conduct (English) Guidelines (810 KB)
2019/07 Halbjahresbericht 2019 Brochure (4 MB)
2019/07 EFPIA Disclosure Code Self-Certification Scheme Policy (175 KB)
2019/04 Roche Position on Collaborating with Patient Groups and Patients Position (305 KB)
2019/02 Roche’s Approach to Tax – General Description and Principles Principles (276 KB)
2019/02 SHE Guidelines Guidelines (1 MB)
2019/01 Roche in Kürze 2018 Brochure (2 MB)
2019/01 Finanzbericht 2018 Brochure (2 MB)
2019/01 Geschäftsbericht 2018 Brochure (8 MB)
2019/01 Einhaltung von Gesetzen Fact Sheet (154 KB)
2019/01 Roche-Berufskrankheitsrate (RIR) und Berufskrankheiten Fact Sheet (240 KB)
2019/01 Roche-Unfallrate (RAR) Fact Sheet (439 KB)
2019/01 Förderung der Biodiversität Fact Sheet (151 KB)
2019/01 Abfallmanagement Fact Sheet (382 KB)
2019/01 Wasserverbrauch Fact Sheet (211 KB)
2019/01 Emissions to water Fact Sheet (192 KB)
2019/01 Andere Emissionen in die Luft Fact Sheet (196 KB)
2019/01 Treibhausgasemissionen Fact Sheet (276 KB)
2019/01 Energieverbrauch Fact Sheet (203 KB)
2019/01 Ökobilanz Fact Sheet (287 KB)
2019/01 SGU-Ausgaben Fact Sheet (211 KB)
2019/01 Wesentliche Themen Fact Sheet (201 KB)
2018/12 Roche Directive Collaborating with Patient Groups and Patients Guidelines (252 KB)
2018/10 Intellectual Property, Fueling Innovation & Advancing Healthcare Position (287 KB)
2018/10 Certificate on Roche's Sustainability Commitments, Initiatives and Performance Fact Sheet (247 KB)
2018/08 Climate Change Risk Management Fact Sheet (153 KB)
2018/09 Leitfaden zur Personalpolitik der Roche-Gruppe Policy (390 KB)
2018/07 Halbjahresbericht 2018 Brochure (2 MB)
2018/06 Group Business Continuity Management Policy Policy (362 KB)
2018/05 Working with Government Officials Guidelines (65 KB)
2013/05 Spenden und nichtkommerzielles Sponsoring Policy (190 KB)
2018/03 Organisationsreglement Policy (189 KB)
2018/03 Bylaws Policy (267 KB)
2018/02 Transporte Fact Sheet (177 KB)
2018/02 Roche in Kürze 2017 Brochure (989 KB)
2018/02 Finanzbericht 2017 Brochure (2 MB)
2018/02 Geschäftsbericht 2017 Brochure (4 MB)
2017/11 Roche Policy on sharing of clinical study information Policy (66 KB)
2017/06 EFPIA Disclosure Code Self-Certification Scheme Policy (53 KB)
2017/05 Benefits - Switzerland Brochure (2 MB)
2017/02 Full Year 2016 Presentation without appendix Brochure (2 MB)
2017/01 Finanzbericht 2016 Brochure (2 MB)
2016/08 Policy on Safety, Security, Health and Environmental Protection Policy (188 KB)
2016/06 Counterfeit Medicinal products FAQs (365 KB)
2016/03 SHE Organization Chart Fact Sheet (47 KB)
2016/03 Verhalten im Wettbewerb Guidelines (184 KB)
2016/03 Statuten Policy (504 KB)
2015/09 Group Insider Policy Policy (198 KB)
2015/05 Roche Specimen Repositories FAQs (219 KB)
2015/02 Directive K18 - Annex 2 (Lighting) Brochure (53 KB)
2014/10 Directive K1 - Annex 5 (Mental Health Protection) Policy (1 MB)
2014/10 Directive K1 - Occupational Health Policy (44 KB)
2014/04 Verhalten im Geschäftsverkehr Guidelines (152 KB)
2014/04 Behaviour in Business (German) Guidelines (126 KB)
2014/04 Behaviour in Business (French) Guidelines (149 KB)
2014/03 PROTOKOLL der 96. ordentlichen Generalversammlung der Aktionare der ROCHE HOLDING AG Fact Sheet (8 MB)
2013/10 Continued Access to Investigational Medicines Policy (295 KB)
2012/03 Risk Management Policy (88 KB)
2009/10 Memberships and International CR Recommendations Fact Sheet (62 KB)

No results found.